FoldRx Pharma Raises $29 Million
FoldRx Pharmaceuticals Inc., a Cambrbidge, Mass.-based developer of drugs to treat diseases of protein misfolding and aggregation, has raised $29 million in third-round funding. Novo Ventures and Morgenthaler Ventures were joined by return backers Healthcare Ventures, Fidelity Biosciences, TPG Biotechnology, Alta Partners and Novartis Venture Funds.
16 June 2010•2 mins read
